Fairvalue-Calculator Fairvalue-Calculator
EN DE

Risanamento SpA (RN) Fair Value & Analysis

Real Estate · IT · Market cap €33.0M

Price€0.0165
Fair Value€0.0100
Upside-39.4%
Quality92/100
Evidence: Low

Fair value as of: Jun 25, 2026

Analysis

Risanamento SpA (RN) currently trades at €0.0165, while our model-based Fair Value estimate is €0.0100 — implying the stock looks roughly 39.4% overvalued today. We read business quality at 92/100 (high quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Risanamento SpA is a property and development company in Italy. The company focuses on redevelopment and development activities, including environmental remediation and public infrastructure works in the metropolitan area of Milan Santa Giulia, located in the south-east of Milan. It also has redevelopment projects in Via Grosio in north-west Milan and Torri di Quartesolo in the province of Vicenza. Risanamento SpA is based in Milan, Italy.

Open the full interactive analysis →

Similar stocks

Vingroup Joint Stock Company (VIC) -85% CBRE Group (CBRE) -46% Plaza S.A (MALLPLAZA) +74% SAGAB (SAGAB) -23% SAGAA (SAGAA) -47% SAGAD (SAGAD) -42%

Frequently asked questions

Is Risanamento SpA (RN) undervalued?
As of Jun 25, 2026, our model estimates a fair value of €0.0100 versus a price of €0.0165 — about −39% (overvalued). Model-based estimate, not financial advice.
What is the fair value of RN?
Our 21-model fair value for Risanamento SpA is €0.0100 (as of Jun 25, 2026), built from audited fundamentals. The current price is €0.0165.
What is the quality score of RN?
Risanamento SpA has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.